⚠ Evidence note: Mechanistic aging biology translates to human interventions slowly and unreliably; model-organism lifespan gains have repeatedly failed to transfer.
Brain Glucose Metabolism Decline in Aging
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-09-24 — Targeting Glial Glycolysis with EGCG Alleviates Parkinson’s Disease in a PINK1 mutant Drosophila Model.: cross-connection with pink1-parkin-mitophagy: Glial glycolysis upregulation acts as the pathogenic metabolic state downstream of neuronal PINK1 loss in a Drosophila PD model, linking cell-type-specific brain glucose handling to mitophagy-failure disease phenotypes. (novelty: 3)
- 2026-09-25 — The Interplay of Metabolic Dysfunction, Neuroinflammation, and Mitochondrial Dysfunction in Balance Impairment: Insights from Type 2 Diabetes Mellitus and Alzheimer’s Disease.: cross-connection with mitochondrial-dysfunction: Review ties skeletal/neural mitochondrial failure to insulin resistance/glucotoxicity in a shared T2DM–AD cycle whose behavioral readout is balance impairment, connecting brain glucose metabolism decline to peripheral and central mitochondrial dysfunction via a common motor-circuit target. (novelty: 3)
- 2026-07-28 — The Role of Brain Lactate Metabolism in Neuroprotection During Healthy Aging: Early human work suggests lactate—delivered via exercise or as an exogenous fuel—shifts brain glucose metabolism toward a more youthful profile; authors propose a young-vs-older adult comparison as a blueprint for restoring age-vulnerable brain energetics (early-stage human trial data plus proposal, not a completed powered RCT). [human-rct] (novelty: 3)
Open questions
Related
Contributing findings
The Role of Brain Lactate Metabolism in Neuroprotection During Healthy Aging
28-jul-2026
novelty 3
per-area 3
strengthens